Department of Physical Therapy, College of Applied Medical Sciences, Imam Abdulrahman Bin Faisal University, Saudi Arabia.
Centre for Physiotherapy and Rehabilitation Sciences, Jamia Millia Islamia, New Delhi, India.
J Bodyw Mov Ther. 2023 Jan;33:128-135. doi: 10.1016/j.jbmt.2022.09.021. Epub 2022 Sep 22.
The objective of the study is to evaluate the best available evidence on the effectiveness of DN in the management of tendinopathy.
Seven randomized control trials were selected following an electronic search in PubMed, Web of Science, Scopus, and SPORTDiscus databases. To be included in the current systematic review, the study had to be an RCT conducted on human participants, which investigated the effect of the DN technique on the management of tendinopathies. Only studies in the English language published in peer-reviewed journals between 1999 and 2020 were included. The methodological quality of the studies was assessed using the PEDro scale.
The PEDro score of the studies ranged from 5 to 9 with a mean score of 6.7 ± 1.2 (mean ± SD). A total of 357 participants were enrolled in the seven included studies, which were on greater trochanteric pain syndrome, lateral epicondylitis, supraspinatus tendinopathy and Achilles tendinopathy. DN was compared with various interventions, including platelet-rich plasma injection, autologous blood injection and non-steroidal anti-inflammatory medication. All the selected studies reported a significant positive effect of DN on pain intensity and other outcome measures, such as patient-specific functional score, disability index, range of motion and health-related quality of life.
The results indicate that DN appears to be as effective as other treatment methods at relieving pain and other symptoms of tendinopathy immediately after treatment and up to 6 months. DN can be considered among the many options available for the management of tendinopathy.
本研究旨在评估 DN 在治疗腱病方面的有效性的最佳现有证据。
通过对 PubMed、Web of Science、Scopus 和 SPORTDiscus 数据库进行电子检索，选择了 7 项随机对照试验。为了纳入本次系统评价，研究必须是一项针对人类参与者的 RCT，研究 DN 技术对腱病管理的影响。仅纳入 1999 年至 2020 年期间以同行评审期刊发表的英语研究。使用 PEDro 量表评估研究的方法学质量。
研究的 PEDro 评分范围为 5 至 9 分，平均得分为 6.7±1.2（均值±标准差）。共有 357 名参与者纳入了 7 项纳入研究，研究对象为转子间疼痛综合征、外侧肱骨髁炎、冈上肌腱病和跟腱病。DN 与包括富血小板血浆注射、自体血注射和非甾体抗炎药在内的各种干预措施进行了比较。所有入选研究均报告了 DN 对疼痛强度和其他结果指标（如患者特定功能评分、残疾指数、活动范围和健康相关生活质量）的显著积极影响。
结果表明，DN 在治疗后即刻和 6 个月内缓解疼痛和腱病的其他症状方面似乎与其他治疗方法同样有效。DN 可被视为治疗腱病的众多选择之一。
